AURA
Aura Biosciences·NASDAQ
--
--(--)
--
--(--)
3.70 / 10
Netural
Fund flow is rated good at 7.4/10, showing positive momentum in small and medium flows, though large and extra-large flows trend negative. Analyst sentiment is overwhelmingly bullish with one Buy rating and no Sell/Strong Sell, but the historical win rate is 0.0%, indicating limited reliability; overall, the analyst consensus is positive yet unproven.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-26
InstitutionEvercore ISI Group
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of AURA?
- AURA holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.70/10 (Netural).
